Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population.
Chad Fanti, MD
Advertisement
Articles by Chad Fanti, MD
Advertisement
Latest Updated Articles
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast CancerPublished: August 12th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
The Lived Experience of Talquetamab Therapy in a Patient With Multiple Myeloma
2
Underscoring Genetic Testing’s Role in Enhancing Ovarian Cancer Care
3
Future Directions in nccRCC
4
Managing Toxicities in BCMA/GPRC5D-Directed Therapies in Multiple Myeloma
5
